X-Message-Number: 874 Date: 03 Jun 92 04:57:19 EDT From: Paul Wakfer <> Subject: Stockholders elect new Cryovita President The following statement was released in Riverside California, May 31, 1992: For further information, contact: Saul Kent -714-780-3252 (Fax) 714-780-5758 At a stockholder's meeting at its offices in Riverside, California today, Paul Wakfer was chosen to replace Hugh Hixon as President and Chief Executive Officer (CEO) of Cryovita Laboratories. Hixon had served as Cryovita's President and CEO ever since the cryonic suspension of Jerry D. Leaf, the company's founder in July 1991. Jerry Leaf founded Cryovita in 1978 in order to conduct low temperature biological research, with the ultimate aim of achieving human suspended animation. In 1979, Cryovita began to offer cryonic suspension services to the Alcor Life Extension Foundation and continued to do so until Leaf was placed into suspension. In the mid 1980s, Cryovita collaborated with Alcor to conduct pioneering experiments in which dogs were placed into liquid state suspended animation (at temperatures just above zero degrees C.) for up to 4 and a half hours, with subsequent full recovery. Wakfer is a suspension member of Alcor, who recently came to Riverside from Toronto, Canada in order to use his talents on behalf of the cryonics movement. In the early 1970s, he fulfilled all his Ph.D. requirements for Mathematical Logic (except the writing of this thesis) at McMaster University in Canada. Wakfer has expertise in computer hardware, software, and operating systems on mainframes, mini- and micro-computers, and ran his own computer consulting business in Toronto from 1985-1990. Wakfer was a mainstay of the Ontario Libertarian Party in the late 1970s and became President of the Libertarian Party of Canada in 1978, before forming his own political party in 1980, which he ran until he became disillusioned with political activity in 1982. "In recent years, Cryovita has been unable to do any research because of increasing demands for cryonic suspension services," said Wakfer after taking office. "I intend to change all that. Although Cryovita will continue to play a role in the cryonic suspension of Alcor members, its primary activity will be research to perfect suspended animation. I intend to get Cryovita rolling by investing some of my own money in the company, and by working tirelessly to help the company succeed. I'm grateful for the opportunity to lead Cryovita and to play a role in advancing the science of cryonics." Cryovita can be reached at EMAIL address Rate This Message: http://www.cryonet.org/cgi-bin/rate.cgi?msg=874